YM 934

Drug Profile

YM 934

Latest Information Update: 09 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yamanouchi
  • Class Antihypertensives
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Asthma; Hypertension; Urinary incontinence

Most Recent Events

  • 20 Aug 1999 A preclinical study has been added to the Genitourinary disorders pharmacodynamics section
  • 14 Sep 1998 No-Development-Reported for Hypertension in Japan (Unknown route)
  • 07 Apr 1998 A clinical study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top